Insignia Financial to Exit S&P/ASX 200 as 4DMedical Joins Benchmark

An announcement from Insignia Financial Ltd ( (AU:IFL) ) is now available.

Insignia Financial Limited is set to leave the S&P/ASX 200 Index as it proceeds with an acquisition by Daintree BidCo Pty Ltd, marking a significant change for the Australian wealth manager’s presence in the benchmark equity gauge. The removal reflects how corporate control events can quickly reshape index composition and may prompt portfolio adjustments by index-tracking funds exposed to the stock.

S&P Dow Jones Indices will delete Insignia Financial from the S&P/ASX 200 before the market opens on April 20, 2026, and will add medical imaging technology firm 4DMedical Limited in its place, shifting a slice of benchmark exposure from financial services to healthcare technology. The index change underscores the dynamic nature of Australia’s flagship index and could alter sector weightings and risk profiles for investors tracking or benchmarking against the S&P/ASX 200.

The most recent analyst rating on (AU:IFL) stock is a Hold with a A$4.75 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.

More about Insignia Financial Ltd

Insignia Financial Limited operates in Australia’s financial services sector, providing wealth management solutions that typically span financial advice, investment products and superannuation administration. The company targets retail and institutional investors seeking managed investment and retirement planning services across the Australian market.

YTD Price Performance: 4.61%

Average Trading Volume: 2,488,877

Technical Sentiment Signal: Buy

Current Market Cap: A$3.2B

See more data about IFL stock on TipRanks’ Stock Analysis page.